| 000 | 01238 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516095245.0 | ||
| 264 | 0 | _c20130319 | |
| 008 | 201303s 0 0 eng d | ||
| 022 | _a1878-4216 | ||
| 024 | 7 |
_a10.1016/j.pnpbp.2012.06.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrierley, Daniel I | |
| 245 | 0 | 0 |
_aDevelopments in harmine pharmacology--implications for ayahuasca use and drug-dependence treatment. _h[electronic resource] |
| 260 |
_bProgress in neuro-psychopharmacology & biological psychiatry _cDec 2012 |
||
| 300 |
_a263-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAlcoholism _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBanisteriopsis _xchemistry |
| 650 | 0 | 4 |
_aCocaine-Related Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aHarmine _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aN,N-Dimethyltryptamine _xpharmacology |
| 650 | 0 | 4 | _aSecondary Prevention |
| 700 | 1 | _aDavidson, Colin | |
| 773 | 0 |
_tProgress in neuro-psychopharmacology & biological psychiatry _gvol. 39 _gno. 2 _gp. 263-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pnpbp.2012.06.001 _zAvailable from publisher's website |
| 999 |
_c21858943 _d21858943 |
||